1. Cellphire Announces Exercise by BARDA of Option 3 of Contract to Develop Platelet-Based Hemostatic

    (April 21, 2020) – Cellphire, Inc., the global leader in long-term stabilization and storage of platelets, announced today that the Biomedical Advanced Research and Development Authority (BARDA), part of the office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, has exercised its third contract option valued […]